Evidence map›Paper›PMID 37492841›Full record

ArticleCureus2023

Segmental Resection With Primary Reconstruction Using a Patient-Specific Implant for Unicystic Ameloblastoma: A One-Year Follow-Up Case Report.

Yashwanth V Satyanarayana Killampalli, Senthilnathan K P, Murugesan Krishnan, Melvin George, Sabari Nathan Rajamoorthy

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yashwanth V Satyanarayana KillampalliOral and Maxillofacial Surgery, Saveetha Dental College and Hospital, Chennai, IND.
Senthilnathan K POral and Maxillofacial Surgery, Saveetha Dental College and Hospital, Chennai, IND.
Murugesan KrishnanOral and Maxillofacial Surgery, Saveetha Dental College and Hospital, Chennai, IND.
Melvin GeorgeOral and Maxillofacial Surgery, Saveetha Dental College and Hospital, Chennai, IND.
Sabari Nathan RajamoorthyOral and Maxillofacial Surgery, Saveetha Dental College and Hospital, Chennai, IND.
Saveetha University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unicystic ameloblastoma is a slow-growing tumor originating from the odontogenic epithelium that can be localized within the lining of a cyst. It commonly affects younger individuals and is frequently found in the posterior mandible. The classification of this tumor is based on histopathological characteristics, distinguishing between the luminal, intraluminal, and mural proliferation of the odontogenic epithelium. Treatment options vary depending on the histology and can range from enucleation to resection with secondary reconstruction. In recent years, patient-specific implants have gained popularity in reconstructive surgeries, particularly in craniomaxillofacial surgery. This case report focuses on a 22-year-old female patient with a mural-type unicystic ameloblastoma. The treatment involved segmental mandibular resection with primary reconstruction using a patient-specific implant to address the mandibular defect. The postoperative healing process and condylar movement were evaluated, and the patient achieved satisfactory results. This case report provides valuable insights into the management of primary reconstruction using a patient-specific implant.

Indexed as

dentalmural ameloblastomapatient specific implant (psi)primary reconstructionquality of life (qol)segmental resection

Identifiers

PMID37492841
PMCPMC10365892
OpenAlexW4381851303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.